Since March 2007, Sergio Roman-Roman is Head of the Translational Research Department at Institut Curie (Paris, France) where he coordinates the preclinical oncology programs and heads a group of scientists and physicians involved in translational research projects. From 2002 to 2007, he was Head of in vitro Pharmacology and Responsible of Prospective Discovery Portfolio Management at ProSkelia Pharmaceuticals (Founding member), bought in 2004 by ProStrakan. From 1998 to 2002, he led a Molecular and Cell Biology laboratory at Aventis Pharma (Bone Diseases group). Sergio Roman-Roman also managed a laboratory in the Department of Immunology, Roussel-Uclaf and Hoechst-Marion-Roussel (1992-1998). Prior to entering the pharmaceutical industry, he trained as a Post-doc fellow at INSERM U333 (Prof. Thierry Hercend) Institut Gustave-Roussy (Villejuif, France). Overall, Sergio Roman-Roman has published more than 60 publications in peer-reviewed Journals and has a H-factor=20 with >2,000 citations.